Pipenzolate bromide

Pipenzolate bromide is a pharmaceutical drug that has been studied as an antispasmodic agent and to treat peptic ulcer.^[1]

Pipenzolate bromide

Clinical data
ATC code	A03AB14 (WHO)
Identifiers
IUPAC name 1-Ethyl-3-[2-hydroxy(diphenyl)acetoxy]-1-methylpiperidinium bromide
CAS Number	125-51-9 Y
PubChem CID	657306
ChemSpider	571430 N
UNII	JPX41DUS2B
ChEMBL	ChEMBL1401367 N
CompTox Dashboard (EPA)	DTXSID2023480
ECHA InfoCard	100.004.311
Chemical and physical data
Formula	C22H28BrNO3
Molar mass	434.374 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC[N+]1(CCCC(C1)OC(=O)C(c2ccccc2)(c3ccccc3)O)C.[Br-]
InChI InChI=1S/C22H28NO3.BrH/c1-3-23(2)16-10-15-20(17-23)26-21(24)22(25,18-11-6-4-7-12-18)19-13-8-5-9-14-19;/h4-9,11-14,20,25H,3,10,15-17H2,1-2H3;1H/q+1;/p-1 N Key:XEDCWWFPZMHXCM-UHFFFAOYSA-M N
NY (what is this?)  (verify)

Mechanism of action

Pipenzolate bromide acts as an antimuscarinic agent. It binds to muscarinic acetylcholine receptors as an antagonist therefore preventing acetylcholine from binding to the receptors.^[1]